The global demand for Meningitis B Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Meningitis is a meninges inflammation. Meninges cover the brain and spinal cord. Meningitis B is a meningococcal disease type caused by the bacteria Neisseria meningitidis. Quarter babies, teens, college students, and boarding school students are at higher risk for infection. Meningitis causes fever, sweating, vomiting, and poor appetite. It can be treated easily with intravenous and oral antibiotics within seven to ten days. Meningitis may be acute or chronic. It can be deadly and severe if not treated promptly.
Market Dynamics
The rising prevalence of meningitis B worldwide drives the global meningitis B treatment market. As per the Centers for Diseases Control and Prevention, over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year. The prevalence is witnessing an increasing trend due to the growing abuse of alcohol and weakening the autoimmune system. The incidence and case-fatality rates for bacterial meningitis are more significant. The increasing launch of new vaccines and drugs and growing approval by the FDA for its use propel market growth. Easy access to vaccination and other treatment and rising research and development on exploring new therapies will amplify market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of meningitis b. The growth and trends of meningitis b industry provide a holistic approach to this study.
Market Segmentation
This section of the meningitis b market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Diagnostic Test
- Lateral Flow Assay
- PCR Assay
- Latex Agglutination Tests
- Elisa Tests
- Culture Tests
- Others
By End-User
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Meningitis B market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Meningitis B Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningitis b market include Eurofins Viracor, Inc., HiberGene Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Qnostics, ELITechGroup, and Abbott Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.